QA: Aquestive Therapeutics Inc. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001398733_2019_Aquestive_Therapeutics_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001398733, Aquestive Therapeutics Inc.

  xvar xval
0 AssetsCurrent 74,201,000
1 IntangibleAssetsNetIncludingGoodwill 204,000
2 PropertyPlantAndEquipmentNet 12,207,000
3 remainder_Assets 239,000
4 LiabilitiesCurrent 32,952,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 43,819,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 72,264,000
9 ResearchAndDevelopmentExpense 23,112,000
10 remainder_Expenses 33,982,000
11 remainder_Revenues 67,982,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 86,851,000
1 Liabilities 76,771,000
2 Expenses 129,358,000
3 Revenues 67,982,000
4 StockholdersEquity 10,080,000
5 NetIncome -61,376,000
6 ComprehensiveNetIncome -61,376,000
7 BaseVar 180,481,000
8 EconomicCapitalRatio -0.538

Edgar->Model Mapping

Feature Distribution

Change over Time